Medical Condition News

RSS

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go on dialysis, seriously limiting their quality of life and placing them at significantly increased risk of death. The incidence of kidney disease is increasing with rising rates of obesity-associated type 2 diabetes, but very little progress has been made towards protecting the kidney's filter barrier during the past 50 years.

16 Nov 2013

ESBC joins with Athena Breast Health Network to advance personalized breast cancer risk assessment

Edith Sanford Breast Cancer (ESBC), part of the Sanford Health system based in Sioux Falls, SD, today announced it is partnering with the Athena Breast Health Network, a University of California program, to advance the use of a personalized breast cancer risk assessment.

16 Nov 2013

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

Satellite Healthcare, one of the nation's first and leading not-for-profit providers of kidney dialysis services and a major sponsor of kidney research, is proud to announce that it has partnered with the National Kidney Foundation to sponsor NKF's free Community Kidney Disease Symposium this Saturday, November 16th in Stockton, California.

16 Nov 2013

Study: Surgical weight loss may be able to reverse the effects of aging

Stanford University researchers say surgical weight loss may turn back the effects of aging at a genetic level, in the first study* of its kind presented here during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity.

16 Nov 2013

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

16 Nov 2013

Experts examine research on low-and-no-calorie sweeteners and effect on weight management

Three leading experts will examine the research on low-and-no-calorie sweeteners and their effect on weight loss and weight management as part of ObesityWeek, the first joint meeting of The Obesity Society and the American Society of Metabolic and Bariatric Surgery.

16 Nov 2013

Diplomat selected as provider of IMBRUVICA capsules for MCL treatment

Diplomat, the country's largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of Mantle Cell Lymphoma.

16 Nov 2013

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

The Pancreatic Cancer Action Network has teamed up with the cast of the USA Network primetime show "Royal Pains" to educate fans and the general public about the severity of pancreatic cancer. Mark Feuerstein, who plays Dr. Hank Lawson, the talented and respected doctor behind a Hamptons medical practice, appears in a new public service announcement for the organization with co-stars Paulo Costanzo, Reshma Shetty, Brooke D'Orsay, and Ben Shenkman.

16 Nov 2013

Intelliject to be recognized with George DiDomizio Industry Award

The Institute for Safe Medication Practices has announced that this year's George DiDomizio Industry Award is being presented to Intelliject, Inc. for pioneering advances in drug/device combination products with the Auvi-Q epinephrine auto-injector (also known as Allerject™ in Canada). Auvi-Q is the first auto-injector with audio as well as visual cues for the emergency treatment of life-threatening allergic reactions.

16 Nov 2013

New automated system improves autism screening rates

An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit.

16 Nov 2013

New technique helps fight deadly pancreatic cancer using 2 types of nanoparticles

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.

16 Nov 2013

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Johns Hopkins undergraduate students have invented a system to shock a dangerously irregular heart back into normal rhythm more safely and effectively.

16 Nov 2013

Study: Collaborative approaches can be effective in fighting high blood pressure

Uncontrolled high blood pressure rates continue to grow despite the availability of proven treatments, but collaborative approaches can be effective in fighting this deadly disease, according to a science advisory from the American Heart Association, the American College of Cardiology and the Centers for Disease Control and Prevention.

16 Nov 2013

Extracts made from herbs may improve learning and memory, study finds

Enhanced extracts made from special antioxidants in spearmint and rosemary improve learning and memory, a study in an animal model at Saint Louis University found.

15 Nov 2013

Study highlights major challenge faced by older adults with severe mental illnesses

Although older adults with serious mental illness didn't have more recorded physical illness and had fewer outpatient visits to primary care physicians, they made more medical emergency department visits and had considerably longer medical hospitalizations than older adults without mental illness according to a study conducted by researchers from the Regenstrief Institute and the Indiana University Center for Aging Research.

15 Nov 2013

Research could refine next generation of drugs to help treat dementia

A £1.1 million grant to understand how one of the brain's key neurotransmitters called 'acetylcholine' influences brain activity has been awarded to University of Bristol researchers. The Wellcome Trust award will help scientists understand more precisely how the release of acetylcholine is changing brain cell activity to influence memory and cognition.

15 Nov 2013

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.

15 Nov 2013

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

New research launched today to coincide with World Diabetes Day which takes place tomorrow, 14th November 2013 revealed that good quality care for young people with type-1 diabetes is unevenly distributed throughout Ireland.

15 Nov 2013

Study: Sofrito helps to prevent cardiovascular diseases and cancer

The combination of tomato, olive oil, garlic and onion in a sofrito increases the amount of polyphenols and carotenoids. These bioactive compounds respectively help to prevent cardiovascular diseases and cancer.

15 Nov 2013

Conceive Plus Fertility Personal Lubricant receives FDA approval

The Pew Research Center reports that in the year 2011, the birth rate in the United States slid by 8%. That kind of statistic would indicate getting pregnant isn't as easy as it used to be. However, pharmaceutical manufacturer SASMAR aims to be at the forefront of helping couples to start families. The FDA has officially approved their OTC sperm friendly fertility personal lubricant, Conceive Plus for sale in the US market.

15 Nov 2013

Medical Condition News

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

ESBC joins with Athena Breast Health Network to advance personalized breast cancer risk assessment

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

Study: Surgical weight loss may be able to reverse the effects of aging

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

Experts examine research on low-and-no-calorie sweeteners and effect on weight management

Diplomat selected as provider of IMBRUVICA capsules for MCL treatment

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

Intelliject to be recognized with George DiDomizio Industry Award

New automated system improves autism screening rates

New technique helps fight deadly pancreatic cancer using 2 types of nanoparticles

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Study: Collaborative approaches can be effective in fighting high blood pressure

Extracts made from herbs may improve learning and memory, study finds

Study highlights major challenge faced by older adults with severe mental illnesses

Research could refine next generation of drugs to help treat dementia

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

Study: Sofrito helps to prevent cardiovascular diseases and cancer

Conceive Plus Fertility Personal Lubricant receives FDA approval

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News